FHS Unternehmensberatung and Recipharm Pharmaceutical Development AB have entered a collaboration under which FHS will market and sell Recipharm’s development services, including formulation development, analytical development, manufacture of clinical trial material and stability studies, to customers in Austria, Germany and Switzerland.    “I am very excited about this collaboration,” said Torkel Gren, sales director, Recipharm. “FHS Unternehmensberatung has through its owner Fritz H. Speck an ...